跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,724 条关于
“Edding Genor Group Holdings Limited”
全部
41,724
临床试验
23,536
药物
793
机构
2,012
资讯
15,383
2个月前
Edding Genor Doses First Patient in Phase Ib/II Trial of Trispecific PD-1/CTLA-4/VEGF Antibody GB268 in Metastatic Breast Cancer
去年
Hansoh Pharma's HS-20093 Granted Breakthrough Therapy Designation for Lung Cancer
去年
Genor Biopharma Secures NMPA Approval for Lerociclib CDK4/6 Inhibitor in Advanced Breast Cancer
去年
Hansoh Pharma's Aumolertinib Plus Chemotherapy Shows Positive Phase III Results in EGFR-Mutated NSCLC
去年
Hansoh Pharma's HS-20093 ADC Granted Breakthrough Therapy Designation for ES-SCLC
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Transcenta Announces Positive Interim Results, Highlights Osemitamab and Blosozumab Progress
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
去年
HBM Holdings Secures NMPA Approval to Begin COPD Drug Trials in China
第 1 页，共 1539 页
上一页
下一页
